These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28692342)

  • 1. Targeting the α4-α5 interface of RAS results in multiple levels of inhibition.
    Spencer-Smith R; Li L; Prasad S; Koide A; Koide S; O'Bryan JP
    Small GTPases; 2019 Sep; 10(5):378-387. PubMed ID: 28692342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
    Nussinov R; Tsai CJ; Jang H
    Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association.
    Whaby M; Wallon L; Mazzei M; Khan I; Teng KW; Koide S; O'Bryan JP
    J Biol Chem; 2022 Dec; 298(12):102661. PubMed ID: 36334633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of RAS function through targeting an allosteric regulatory site.
    Spencer-Smith R; Koide A; Zhou Y; Eguchi RR; Sha F; Gajwani P; Santana D; Gupta A; Jacobs M; Herrero-Garcia E; Cobbert J; Lavoie H; Smith M; Rajakulendran T; Dowdell E; Okur MN; Dementieva I; Sicheri F; Therrien M; Hancock JF; Ikura M; Koide S; O'Bryan JP
    Nat Chem Biol; 2017 Jan; 13(1):62-68. PubMed ID: 27820802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.
    Muratcioglu S; Aydin C; Odabasi E; Ozdemir ES; Firat-Karalar EN; Jang H; Tsai CJ; Nussinov R; Kavakli IH; Gursoy A; Keskin O
    J Mol Biol; 2020 Feb; 432(4):1199-1215. PubMed ID: 31931009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
    Khan I; Spencer-Smith R; O'Bryan JP
    Oncogene; 2019 Apr; 38(16):2984-2993. PubMed ID: 30573767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer-specific nanoclustering.
    Guzmán C; Šolman M; Ligabue A; Blaževitš O; Andrade DM; Reymond L; Eggeling C; Abankwa D
    J Biol Chem; 2014 Apr; 289(14):9519-33. PubMed ID: 24569991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTP-Dependent K-Ras Dimerization.
    Muratcioglu S; Chavan TS; Freed BC; Jang H; Khavrutskii L; Freed RN; Dyba MA; Stefanisko K; Tarasov SG; Gursoy A; Keskin O; Tarasova NI; Gaponenko V; Nussinov R
    Structure; 2015 Jul; 23(7):1325-35. PubMed ID: 26051715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers.
    Jang H; Muratcioglu S; Gursoy A; Keskin O; Nussinov R
    Biochem J; 2016 Jun; 473(12):1719-32. PubMed ID: 27057007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
    Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector Binding Sequentially Alters KRAS Dimerization on the Membrane: New Insights Into RAS-Mediated RAF Activation.
    Lee SY; Eun HJ; Lee KY
    Adv Sci (Weinh); 2024 Oct; 11(38):e2401530. PubMed ID: 39138901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel switch region regulates H-ras membrane orientation and signal output.
    Abankwa D; Hanzal-Bayer M; Ariotti N; Plowman SJ; Gorfe AA; Parton RG; McCammon JA; Hancock JF
    EMBO J; 2008 Mar; 27(5):727-35. PubMed ID: 18273062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers.
    Najumudeen AK; Posada IM; Lectez B; Zhou Y; Landor SK; Fallarero A; Vuorela P; Hancock J; Abankwa D
    Biochemistry; 2015 Dec; 54(49):7212-21. PubMed ID: 26568031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition.
    Jin T; Lavoie H; Sahmi M; David M; Hilt C; Hammell A; Therrien M
    Nat Commun; 2017 Oct; 8(1):1211. PubMed ID: 29084939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an H-Ras nanocluster disrupting peptide.
    Steffen CL; Manoharan GB; Pavic K; Yeste-Vázquez A; Knuuttila M; Arora N; Zhou Y; Härmä H; Gaigneaux A; Grossmann TN; Abankwa DK
    Commun Biol; 2024 Jul; 7(1):837. PubMed ID: 38982284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic K-ras segregates at spatially distinct plasma membrane signaling platforms according to its phosphorylation status.
    Barceló C; Paco N; Beckett AJ; Alvarez-Moya B; Garrido E; Gelabert M; Tebar F; Jaumot M; Prior I; Agell N
    J Cell Sci; 2013 Oct; 126(Pt 20):4553-9. PubMed ID: 23943869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR in integrated biophysical drug discovery for RAS: past, present, and future.
    Marshall CB; KleinJan F; Gebregiworgis T; Lee KY; Fang Z; Eves BJ; Liu NF; Gasmi-Seabrook GMC; Enomoto M; Ikura M
    J Biomol NMR; 2020 Nov; 74(10-11):531-554. PubMed ID: 32804298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe.
    Bery N; Legg S; Debreczeni J; Breed J; Embrey K; Stubbs C; Kolasinska-Zwierz P; Barrett N; Marwood R; Watson J; Tart J; Overman R; Miller A; Phillips C; Minter R; Rabbitts TH
    Nat Commun; 2019 Jun; 10(1):2607. PubMed ID: 31197133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS
    Zhou ZW; Ambrogio C; Bera AK; Li Q; Li XX; Li L; Son J; Gondi S; Li J; Campbell E; Jin H; Okoro JJ; Xu CX; Janne PA; Westover KD
    Cancer Res; 2020 Sep; 80(17):3719-3731. PubMed ID: 32605999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-Ras
    Feng H; Zhang Y; Bos PH; Chambers JM; Dupont MM; Stockwell BR
    Biochemistry; 2019 May; 58(21):2542-2554. PubMed ID: 31042025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.